Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Physiologic MR Imaging in Distinguishing Benign From Malignant Salivary Gland Tumors

NCT04452162 is registered in ClinicalTrials.gov with Abramson Cancer Center at Penn Medicine as lead sponsor.

NCT NCT04452162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04452162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Physiologic MR Imaging in Distinguishing Benign From Malignant Salivary Gland Tumors
Lead sponsor
Abramson Cancer Center at Penn Medicine
Phase
Not applicable
Overall status
Recruiting
Start date
August 25, 2020
Completion date
June 30, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

salivary gland tumor